Today, members of CDC’s Advisory Committee on Immunization Practices (ACIP) began their long awaited three day meeting to review cases of myocarditis reported in adolescents and young adults after receiving experimental COVID-19 vaccines.
🔹Over 800 cases of suspected myocarditis have been reported, of which almost 500 cases are reported in people under the age of 30.
🔹85 cases of suspected myocarditis/pericarditis were reported in teens 16 or 17 years old.
🔹Over 200 cases of suspected myocarditis after a COVID-19 vaccine were reported among young adults ages 18-24. This incidence of myocarditis is higher than expected for this age group.
🔹 As of May 31, 2021, only approximately 9% of the COVID-19 vaccine doses administered were among those aged 16-24, thus why this higher-than-normal rate of possible myocarditis cases may be occurring warrants investigation.
Simone Scott, 19
Simone Scott, a 19-year-old freshman at Northwestern University, died of complications from a heart transplant she underwent after developing what her doctors believe was myocarditis following her second dose of the Moderna COVID vaccine.
Scott received the second dose on May 1, and on May 11, visited a doctor on campus because she wasn’t feeling well.
On May 16, she texted her father complaining of dizziness and fatigue. He called campus police who, when they checked in on her, had to administer CPR.
After multiple interventions, including hooking Scott to an ECMO machine that mirrors the function of the heart so her own heart could rest, doctors determined she needed a heart replacement. She died June 11.
Scott’s mother told local media, “I still feel like she’s here, even though I know she’s not and it just feels like such a waste.”
Simone’s parents shared that Northwestern University was her top and only choice for college. During the application and admissions process, her parents encouraged her to look at other schools, but Simone insisted that “Northwestern fit her.”
A double major in broadcast journalism and political science/pre-law, Simone was a reporter and co-anchor for Northwestern News Network, where she built strong bonds during her first year at the University.
Scott’s doctors said it appears she suffered from myocarditis.
Justin Harrington, 21
On June 15, a 21-year-old New Jersey student suffered severe heart inflammation after receiving his second dose of Moderna’s COVID vaccine.
Justin Harrington, a student at New Jersey Institute of Technology, where he was required to get the vaccine in order to attend classes in the fall, experienced flu-like symptoms followed by heart pain within eight to 12 hours of receiving the vaccine.
His father said when he called the dean of NJIT prior to his son getting vaccinated and asked why the school is forcing young people who are at little risk of serious illness from COVID to get the vaccine, the dean replied that unless his son had a valid medical or religious exemption, it was a requirement.
“I am not ‘anti-vax,’” Timothy Harrington, Justin’s father said. “I am ‘anti-forced-vaxxed.’ They’re forcing these kids to get a vaccine even though they’re not affected by COVID or have already had it.”
In an exclusive interview with The Defender, Justin’s father, Timothy Harrington, said his son felt different after the second shot. Every time his heart beat it hurt and he felt pressure,” Harrington said. “Then he developed heart pain down both arms.”
Harrington said his son, who has no underlying medical conditions, did not experience heart pain with his first dose of the vaccine.
Although Justin has since been released from the hospital, he has to wear a heart monitor and take four different medications for six months, has to sleep propped up, can’t exert himself and he’s missing out on one of the most important times of his life, his father said.
As for Justin’s recovery, Harrington said, “He has minor scarring on his heart and doctors hope they caught it early enough that there will be no other issues — but it’s pure conjecture at this point.”
CDC: “Continue Monitoring”
The CDC indicated they are continuing to monitor VAERS and the VSD for cases of myocarditis, which may be occurring more often in males rather than females; more frequently after the second dose rather than the first dose of vaccine; and with symptoms typically appearing within 3 days of the dose of vaccine. The CDC also urges clinicians to consult with cardiologists for patients appearing with symptoms of myocarditis or a heart-related condition for additional testing and treatment.